Abiopharma

🔍 Steven Edelman (Executive)

Company: Senseonics Holdings, Inc. (SENS)

Report Date: 2026-01-02

Detailed Transactions and Holdings:

• Acquired 2,185 shares of Common Stock at $5.89 per share (Direct)
  Date: 2026-01-02 | Code: A | equity_swap_involved: 0 | shares_owned_after: 76,893.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: This common stock was issued to the Reporting Person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees. The number of shares of common stock is equal to $12,869.65 divided by $5.89, the closing price of Issuer's common stock on the Nasdaq Global Select Market on January 2, 2026.